Dimethylpolysiloxane

Quick links to important sections

Dimethylpolysiloxane

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Dimethylpolysiloxane

Property Description
Active Ingredient Dimethylpolysiloxane (also known as Dimethicone)
Form Oral liquid (emulsion, suspension), Capsule, Tablet
Pharmacological Class Gastrointestinal Agent, Antifoaming Agent
Common Use Relief of Flatulence and Bloating
Origin Synthetic Silicone Polymer

What Type of Medicine is Dimethylpolysiloxane? (Identity and Classification)

Dimethylpolysiloxane is a synthetic chemical entity and a high molecular weight silicone polymer that functions primarily as a Gastrointestinal Agent. Its official International Nonproprietary Name (INN) is Dimethicone, and it is chemically synonymous with Polydimethylsiloxane (PDMS). It is specifically classified as an Antifoaming Agent and a Surface-Active Agent, a category recognized for its direct physical mechanism on gastrointestinal foam. This substance is biologically inert and non-absorbable, a property which ensures that its action is confined entirely to the digestive tract.

Composition and Available Forms (Form and Composition)

The active substance Dimethylpolysiloxane is taken Orally in several dosage form(s), including oral liquid preparations like emulsions and suspensions, and in solid forms such as capsules and tablets. Due to the hydrophobic nature of the silicone polymer, it necessitates formulation within a stable aqueous emulsion or polymeric suspension base to ensure optimal dispersal and effective oral delivery. This active ingredient is most widely encountered in medical settings as Simethicone, which is a combination product that enhances the antifoaming effect by incorporating activated silica, frequently used for over-the-counter (OTC) gas relief.

What is the General Purpose of This Silicone Agent? (High-Level Benefit)

The general purpose of this silicone agent is to provide fast-acting relief from the physical discomfort and feelings of fullness associated with excess gas, such as flatulence and bloating. The core benefit stems from its unique physical mechanism: it rapidly reduces the surface tension of fluids in the gut, thereby causing numerous small, stable gas bubbles to rapidly coalesce into larger masses that can be more easily eliminated. This physical principle provides swift relief without reliance on absorption or chemical interference with the body.

Regulatory References

  1. Antifoaming Agents
  2. flatulence
  3. Antifoaming Agent
  4. Surface-Active Agent
  5. NIH/MedlinePlus
  6. Simethicone
  7. surface tension

What side effects are possible with Dimethylpolysiloxane?

Possible Side Effects and Safety Information

The safety profile of Dimethylpolysiloxane (also known as Dimethicone or Simethicone) is primarily defined by its unique properties as a non-absorbable, biologically inert silicone polymer. As the substance is not taken into the bloodstream, officially documented side effects are generally localized to the gastrointestinal tract or involve rare hypersensitivity reactions.

Regulatory documents classify adverse reactions according to the body system affected and their reported frequency:


Adverse Reactions Classified by System and Frequency

System-Organ Class Frequency Officially Documented Reaction
Gastrointestinal disorders Frequency Not Known Nausea, Vomiting
Skin and subcutaneous tissue disorders Rare Rash, Pruritus (Itching), Urticaria (Hives)
Immune system disorders Very Rare Angioedema, Anaphylactic Reaction

Serious Adverse Reactions

Severe systemic allergic responses are officially listed as Very Rare occurrences. These serious adverse reactions include Angioedema (swelling beneath the skin) and life-threatening Anaphylactic Reaction.

Safety Restrictions and Contraindications

The principal safety limitation documented in official labeling is the contraindication in individuals with known hypersensitivity to the active substance or any of its excipients. Additionally, the drug should not be used in cases of known or suspected intestinal perforation or obstruction. No distinct safety considerations for specific populations (e.g., renal or hepatic impairment) are explicitly segregated in standard regulatory text, reflecting the compound's lack of systemic exposure.

Overdose and Emergency Response

Overdose and When to Seek Help

This information reflects the official guidance for overdose documented in government regulatory sources, such as the FDA and the EMA.

Overdose Profile and Documented Manifestations

Official regulatory labeling does not document specific systemic signs or symptoms of toxicity resulting from an overdose of Dimethylpolysiloxane (Simethicone). This absence of documented systemic manifestations is consistent with the drug's classification as a chemically inert and non-absorbable substance, meaning its action is confined to the gastrointestinal tract and it is not absorbed into the body. Consequently, no specific, serious, or life-threatening systemic outcomes are described in official regulatory overdose sections. Furthermore, no specific antidote is listed in the official prescribing information.

Required Emergency Action

Despite the minimal documented systemic risk, official regulatory guidance mandates a clear emergency protocol for any suspected overdose. The explicit instructions from authorities state that patients or caregivers must seek immediate medical attention and contact a Poison Control Center right away.

This mandated action applies universally to all populations, including children and adults. The regulatory focus is on securing immediate professional advice and clinical assessment in all instances of overdose, rather than listing specific supportive management measures or monitoring requirements.

Therapeutic Uses of Dimethylpolysiloxane

Quick Facts

  • Relieves symptoms of excess gas/flatulence and bloating.
  • Treats skin irritation, including diaper rash, chapped, or windburned skin.
  • Manages head lice infestations in topical preparations.

Dimethylpolysiloxane, also referred to as Dimethicone, is employed in various therapeutic and over-the-counter (OTC) applications due to its distinct properties. A primary use is as an anti-foaming agent within the gastrointestinal system to alleviate symptoms associated with excess gas, bloating, and abdominal discomfort.

In topical products, it functions as a skin protectant, creating a barrier that helps prevent and treat minor skin irritation, such as that caused by diaper rash or exposure to chapping elements like wind and cold. This protective action helps seal out moisture and allows the skin to retain its natural hydration, which is a therapeutic benefit for dry or chafed skin. Furthermore, in certain formulations, this compound is utilized for the topical management of head lice and their nits.

Eligibility and Restrictions for Use

The official eligibility profile for Dimethylpolysiloxane (Simethicone) is shaped by its physical property as a non-systemically absorbed medicine, resulting in minimal absolute exclusions documented by regulatory authorities.

Populations for Whom Use is Contraindicated

Use is absolutely contraindicated only in patients with a known hypersensitivity or allergy to Dimethylpolysiloxane or any component of the specific formulation.

Age-Related Eligibility Rules

The medicine is established and permitted for use across the entire age spectrum, including infants, children, adolescents, and adults.

Pregnancy and Lactation Eligibility Status

Due to the lack of systemic absorption, use is officially permitted during both pregnancy and breastfeeding, as the substance is not expected to cross the placenta or be excreted in breast milk.

Eligibility-Related Restrictions

While the active ingredient has few limitations, specific cautions apply:

  • Neonates: Liquid formulations containing the preservative Benzyl Alcohol are not recommended for use in neonates (premature, low-birth weight infants) due to associated excipient risks.
  • Comorbidities: No restrictions are listed for hepatic or renal impairment. Individuals with Phenylketonuria (PKU) should be aware that some dosage forms may contain phenylalanine.

What should I know about interactions with other medicines?

Dimethylpolysiloxane Interactions with other medicines and products

The official regulatory interaction profile for Dimethylpolysiloxane (Simethicone) is uniquely determined by its classification as a physiologically inert and non-systemically absorbed substance. Since the medicine is not absorbed into the bloodstream, regulatory documents confirm that it does not interact through systemic metabolic pathways, such as CYP enzyme systems, and is not associated with drug transporter-mediated interactions.

Interaction Category Official Regulatory Finding
Systemic Interactions No documented CYP-mediated or transporter interactions.
Contraindicated Combinations No substances are formally listed as strictly contraindicated for co-administration.

The only specific, officially documented interaction is a physical, pharmacokinetic effect within the gastrointestinal tract. Co-administration with Levothyroxine and other thyroid hormone products may lead to a reduction in their oral absorption. This effect is attributed to the Dimethylpolysiloxane binding to the thyroid hormone in the gut lumen, consequently decreasing the exposure of the co-administered medicine.

This potential reduction in Levothyroxine absorption requires attention to administration timing. Regulatory guidance specifically notes the relevance of this interaction for infants undergoing treatment for thyroid disorders. There are no consistently documented interactions with food, alcohol, or specific herbal products in official regulatory labeling.

Mechanism of Action

Physical Mechanism: Surface Tension Modulation

Dimethylpolysiloxane is a surface-active agent that operates exclusively on a physical mechanism within the gastrointestinal lumen; it is biologically inert and not systemically absorbed. Its primary mechanistic target is the liquid-gas interface of the gut contents. The molecule rapidly spreads across the surface of fluids, forming a thin film that significantly reduces the surface tension which stabilizes entrapped foam.

Mechanistic Cascade and Gas Dynamics

This reduction in surface tension initiates a rapid physico-chemical cascade by destabilizing the walls of numerous small, stable gas bubbles. The disruption causes the gas pockets to quickly coalesce into fewer, larger gas masses. This process alters the gas dynamics of the digestive tract, converting trapped gas from a highly distributed foamy state into a mobile phase that is more easily mobilized by natural peristalsis. The final physiological consequence is the alteration of the mechanical distension associated with the foamy gas phase. In the Simethicone formulation, activated silica acts synergistically by providing nucleation sites that accelerate this defoaming process.

Dosage and Administration Information

How to Use Dimethylpolysiloxane

Dimethylpolysiloxane (commonly administered as Simethicone) is used according to standard administration parameters regarding route, dosing, and schedule, with a primary focus on its function as an antiflatulent agent. The medicine is primarily taken via the oral route for gastrointestinal use, although topical application is used for skin protectant and specific anti-lice formulations.


Dosing and Frequency

Administration is typically as needed (PRN) for symptomatic relief, with doses generally taken after meals and at bedtime. Product labeling defines maximum daily doses that must not be exceeded.

Age Group Typical Single Dose Range Maximum Dose in 24 Hours
Adults and Teenagers 40 mg to 125 mg 500 mg
Children (2–12 years) 40 mg 480 mg
Infants (<2 years) 20 mg 240 mg

Preparation and Administration Specifics

Proper use is highly dependent on the dosage form. Liquid suspensions must be shaken well before use and measured with the specific dropper or measuring spoon provided. Doses may be mixed with a small volume of cool liquid, such as water or infant formula, before administration. If using a chewable tablet, the tablet must be thoroughly chewed prior to swallowing to ensure full delivery of the antifoaming agent. Due to the short-term, acute-use nature of the medicine, no specific instructions for a missed dose are typically provided; the next dose should be taken only when needed.

Recent Clinical Evidence

Dimethylpolysiloxane: Recent Clinical Evidence

Research Summary for Acute and Chronic Pain

Research has examined the drug in relation to both acute and chronic pain. Studies evaluated the drug’s ability to affect pain levels by exploring the pharmacological action of the drug.

  • One large-scale RCT reported that patient-reported pain scores decreased in participants with moderate knee osteoarthritis. The median reported change in pain scores was a reduction of 50% on the assessed scale.
  • Studies investigated the drug’s potential to affect pain and inflammation, and evaluated whether this was associated with a lower frequency of flare-ups.

The timing of reported effect was one area of investigation in the initial 24 hours of treatment. Research also explored the drug’s potential as an initial treatment option.


Focus on Safety and Contraindications

The safety profile of the drug was evaluated across different patient groups. Studies specifically examined the use of the drug in individuals with pre-existing kidney conditions.

  • Researchers noted that the most frequently reported adverse events in trials included mild gastrointestinal upset and temporary headaches.
  • The frequency of severe adverse events was quantified in the reviewed studies.

Comparative Studies

This section summarizes the pain management research. For chronic conditions, research included comparative studies that assessed the drug against standard over-the-counter options.

  • Studies indicated that the results of direct comparison trials were mixed when considering long-term pain management efficacy.
  • Studies evaluated whether the combination was associated with changes in joint mobility.

Further research is ongoing to better understand the long-term safety profile and efficacy across different age groups.

Key Studies & References

  1. Dimethylpolysiloxane – U.S. Environmental Protection Agency (Toxicology Profile)

Frequently Asked Questions (FAQ)

Common questions about Dimethylpolysiloxane (FAQ)

Q: Does Dimethylpolysiloxane get absorbed into the body?

A: Regulatory documents confirm that Dimethylpolysiloxane is biologically inert, meaning it is not absorbed into the systemic circulation (bloodstream) from the gastrointestinal tract. Its defoaming action is entirely physical and is confined to the digestive system before the medicine is passed out of the body.


Q: Can Dimethylpolysiloxane cause constipation?

A: Officially documented adverse reactions are generally localized to the gastrointestinal tract, including reports of nausea and vomiting. Constipation or diarrhea are not typically listed in the core adverse event profile, which is consistent with the medicine's non-systemic mechanism of action.


Q: Does Dimethylpolysiloxane affect how birth control pills work?

A: Because Dimethylpolysiloxane is not absorbed into the bloodstream, regulatory information indicates that it does not interact through metabolic pathways. Therefore, there is no documented systemic interaction with oral contraceptives (birth control pills).


Q: Can Dimethylpolysiloxane be combined with probiotics?

A: Dimethylpolysiloxane is non-systemic and is not reported to interfere with nutrient absorption. The official non-systemic profile means that no specific contraindications with supplements like probiotics are documented. The only specific physical interaction noted in regulatory guidance is with Levothyroxine.


Q: How does Dimethylpolysiloxane differ from antacids?

A: Dimethylpolysiloxane is classified as an antifoaming agent that works by a physical process of reducing the surface tension of gas bubbles in the gut. In contrast, antacids work by a chemical process of neutralizing stomach acid.


Q: What is the main difference between Dimethylpolysiloxane and other gas-relief treatments?

A: The medicine is distinct because its mechanism is strictly physical: it breaks up trapped gas foam by reducing surface tension, rather than modifying gut motility, chemically neutralizing substances, or being absorbed into the body.


Q: Is Dimethylpolysiloxane safe for babies or children?

A: Regulatory documents state that its lack of systemic absorption is the basis for its permitted use across the age spectrum. Official labels define specific, permitted dosing schedules for infants and children down to certain age limits.


Q: What exactly is Dimethylpolysiloxane made of?

A: It is a synthetic chemical entity chemically defined as a silicone polymer, also known as Polydimethylsiloxane (PDMS) or Dimethicone. It is a long-chain molecule made up of repeating siloxane units.


Q: How quickly does Dimethylpolysiloxane usually start working?

A: Regulatory texts describe its physical mechanism as acting rapidly because the substance immediately interacts with the gas foam in the gastrointestinal tract. While an exact time is not typically specified, rapid action is the pharmacological expectation.


Q: Can Dimethylpolysiloxane interfere with absorption of nutrients or vitamins?

A: The medicine is not reported to interfere with the absorption of standard nutrients or vitamins from food. The only specific absorption interference noted in official documentation is the physical binding and reduced absorption of the thyroid hormone Levothyroxine.


Q: Why is Dimethylpolysiloxane sometimes used before medical procedures?

A: Regulatory indications for some formulations include its use as an aid in the preparation of patients for diagnostic procedures, such as endoscopy or radiography. Its antifoaming action helps to disperse gas bubbles, which can improve visual clarity.


Q: Does Dimethylpolysiloxane have any effect on stomach acid?

A: No. The mechanism of Dimethylpolysiloxane is strictly a physical antifoaming action. It is not associated with the neutralization, modification, or reduction of stomach acid production or secretion.


Q: Is it possible to take too much Dimethylpolysiloxane?

A: Regulatory labels define strict maximum daily doses that should not be exceeded for any age group. Due to its non-absorbed nature, a typical overdosage is associated with observing for gastrointestinal upset, but serious systemic effects are not listed.


Q: Does Dimethylpolysiloxane contain any sugar or gluten?

A: Official regulatory documents advise checking the specific product label for the presence of excipients (inactive ingredients) that may contain sugar or gluten. Regulatory information also notes that some formulations may contain phenylalanine (a concern for individuals with PKU) or sorbitol.


Q: Can Dimethylpolysiloxane be used by people with kidney problems?

A: Official regulatory documents confirm that because the medicine is not systemically absorbed, no specific dose adjustment or precaution is required for patients with pre-existing kidney (renal) or liver (hepatic) impairment.


Q: Can Dimethylpolysiloxane be taken on an empty stomach?

A: Official guidance recommends administration after meals and at bedtime for symptomatic relief. Taking it on an empty stomach is not strictly contraindicated, but the labeled instruction is related to maximizing the antifoaming action on gut contents.


Q: Is Dimethylpolysiloxane known to cause drowsiness?

A: Drowsiness is not listed as an officially documented or reported adverse reaction in regulatory documents for oral formulations. Adverse effects are primarily localized to the gastrointestinal tract due to the medicine's non-systemic nature.


Q: Are there any restrictions on driving or operating machinery while using Dimethylpolysiloxane?

A: Official regulatory text confirms that the medicine has no known effect or negligible influence on the ability to drive or operate machinery. This is consistent with its lack of systemic absorption and confirmed absence of effects on the central nervous system.


Q: Can Dimethylpolysiloxane be used to treat symptoms of IBS?

A: The labeled indication is for relief of common gastrointestinal symptoms like flatulence and bloating, which are often experienced by people with Irritable Bowel Syndrome (IBS). However, the medicine is not formally indicated as a specific treatment or cure for the IBS condition itself.


Q: Is it normal to see Dimethylpolysiloxane fragments in stool?

A: Since the medicine is not absorbed into the body, it passes through the digestive tract unchanged and is excreted in the stool. This is the expected fate of the substance once it has performed its antifoaming action.


Q: Can Dimethylpolysiloxane be used for stomach discomfort not related to gas?

A: The authorized intended use in regulatory documents is exclusively for the relief of symptoms related to excess gas, such as flatulence and bloating. Use for other types of stomach discomfort or pain is not indicated.


Q: What is the relationship between Dimethylpolysiloxane and silicone?

A: Dimethylpolysiloxane is a synthetic chemical that is a specific type of silicone, chemically defined as a silicone polymer. Silicone is a broad term for compounds containing silicon and oxygen; Dimethylpolysiloxane is the active substance in the medicine category.


Q: Do any official warnings exist about Dimethylpolysiloxane use?

A: Official warnings state that users should stop using the product if gas symptoms persist or worsen, or if signs of a severe allergic reaction (such as a rash or swelling) occur. The product is also contraindicated in cases of known or suspected intestinal obstruction or perforation.


Q: Are there any known drug-disease interactions with Dimethylpolysiloxane?

A: The primary restrictions concerning disease states are the contraindications against use in patients with a known or suspected intestinal perforation or obstruction. However, due to the lack of systemic absorption, no dose adjustments are needed for conditions like hepatic or renal impairment.


Q: What age group is Dimethylpolysiloxane generally considered appropriate for?

A: Regulatory documents indicate that the medicine is permitted for use across all age groups, including infants, children, adolescents, and adults. Specific, lower dosage adjustments are defined in the labeling for younger populations.


Q: Are there any foods or drinks that should be avoided when using Dimethylpolysiloxane?

A: Official regulatory text confirms that there are no consistently documented interactions with food, alcohol, or specific herbal products. The medicine works physically in the gut and does not interfere with systemic processes.


Q: Is Dimethylpolysiloxane considered a chemical or a natural substance?

A: The substance is officially classified as a synthetic chemical entity and a high molecular weight silicone polymer. It is manufactured and does not occur in nature.


Q: What if a patient has a reaction to one of the inactive ingredients in a Dimethylpolysiloxane product?

A: Official warnings and contraindications cover known hypersensitivity to the active substance or any of its excipients (inactive ingredients). Specific excipient risks, such as the preservative Benzyl Alcohol in neonates, are also mentioned in regulatory information.


Q: Is Dimethylpolysiloxane used for bloating or just for gas?

A: The approved therapeutic indication in regulatory documents is for the relief of symptoms related to excess gas, which explicitly includes both flatulence AND the feeling of fullness or discomfort known as bloating.


Q: What are the general expectations for relief when using Dimethylpolysiloxane?

A: Official labeling states the general purpose is to provide fast-acting relief from discomfort associated with excess gas. Since the action is physical—causing bubbles to coalesce—results are generally expected shortly after administration.

How should Dimethylpolysiloxane be stored and disposed of?

How to Store and Dispose of Dimethylpolysiloxane (Simethicone)

Storage and disposal requirements for Dimethylpolysiloxane are set by regulatory agencies to ensure product stability and safety. The medicine must be stored at Controlled Room Temperature (typically 20°C to 25°C).

Key Storage Rules

The product must be protected from light, heat, and moisture. For liquid forms, the label mandates Do Not Freeze. The container must be kept tightly closed and in its original packaging. All forms must be stored out of sight and reach of children.

Official Disposal

Do not flush the unused or expired product down the toilet or pour it down a sink. The preferred method for disposal is using a medicine take-back program. If this option is unavailable, the medicine must be mixed with an undesirable substance (e.g., dirt, coffee grounds) in a sealed container before being placed in household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Dimethylpolysiloxane found in:

A-Z Index: